Hexermine
Brand names,
Hexermine
Analogs
Hexermine
Brand Names Mixture
Hexermine
Chemical_Formula
C8H11NO3
Hexermine
RX_link
No information avaliable
Hexermine
fda sheet
Hexermine
msds (material safety sheet)
Hexermine
Synthesis Reference
No information avaliable
Hexermine
Molecular Weight
169.178 g/mol
Hexermine
Melting Point
207 oC
Hexermine
H2O Solubility
2.2E+005 mg/L
Hexermine
State
Solid
Hexermine
LogP
-0.784
Hexermine
Dosage Forms
Capsules
Hexermine
Indication
For the treatment of vitamin B6 deficiency and for the prophylaxis of isoniazid-induced peripheral neuropathy.
Hexermine
Pharmacology
Vitamin B6 (pyridoxine) is a water-soluble vitamin used in the prophylaxis and treatment of vitamin B6 deficiency and peripheral neuropathy in those receiving isoniazid (isonicotinic acid hydrazide, INH). Vitamin B6 has been found to lower systolic and diastolic blood pressure in a small group of subjects with essential hypertension. Hypertension is another risk factor for atherosclerosis and coronary heart disease. Another study showed pyridoxine hydrochloride to inhibit ADP- or epinephrine-induced platelet aggregation and to lower total cholesterol levels and increase HDL-cholesterol levels, again in a small group of subjects. Vitamin B6, in the form of pyridoxal 5'-phosphate, was found to protect vascular endothelial cells in culture from injury by activated platelets. Endothelial injury and dysfunction are critical initiating events in the pathogenesis of atherosclerosis. Human studies have demonstrated that vitamin B6 deficiency affects cellular and humoral responses of the immune system. Vitamin B6 deficiency results in altered lymphocyte differentiation and maturation, reduced delayed-type hypersensitivity (DTH) responses, impaired antibody production, decreased lymphocyte proliferation and decreased interleukin (IL)-2 production, among other immunologic activities.
Hexermine
Absorption
Readily absorbed
Hexermine
side effects and Toxicity
Oral Rat LD50 = 4 gm/kg. Toxic effects include convulsions, dyspnea, hypermotility, diarrhea, ataxia and muscle weakness.
Hexermine
Patient Information
No information avaliable
Hexermine
Organisms Affected
Humans and other mammals